Filing Details
- Accession Number:
- 0001127602-23-021000
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-19 16:14:39
- Reporting Period:
- 2023-07-17
- Accepted Time:
- 2023-07-19 16:14:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703647 | Frequency Therapeutics Inc. | FREQ | Pharmaceutical Preparations (2834) | 472324450 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1785288 | L. David Lucchino | C/O Frequency Therapeutics, Inc. 75 Hayden Ave, Suite 300 Lexington MA 02421 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-07-17 | 2,775 | $0.68 | 702,807 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-07-18 | 2,968 | $0.56 | 699,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.59 to $0.72. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.55 to $0.58. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Billionaire Hedge Funds
